Rhenman & Partners Asset Management AB
Position in RPRX — Royalty Pharma plc
CIK 1599882
Stockholm, V7
Position in RPRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$11,177,010
+$3,197,850 QoQ
Shares Held
233,000
+12.8% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rhenman & Partners Asset Management AB holds $297,378,771 across 37 Biotechnology names. RPRX ranks #8 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
48,100 | $37,163,984 | |
| 2 | INSM |
INSMED Inc
|
159,760 | $26,123,955 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
43,485 | $19,417,791 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
75,890 | $14,347,004 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
24,050 | $12,589,453 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
207,000 | $11,693,430 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
34,465 | $11,403,434 | |
| 8 | RPRX |
Royalty Pharma plc
This page
|
233,000 | $11,177,010 |
All Filings in RPRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,177,010 | 233,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,979,160 | 206,500 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,119,880 | 258,500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $12,394,320 | 344,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $12,794,430 | 411,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $15,178,450 | 595,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $17,355,915 | 613,500 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $14,363,659 | 544,697 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $16,542,447 | 544,697 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $12,070,188 | 429,697 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,071,000 | 150,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,611,000 | 150,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,944,950 | 165,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,496,800 | 215,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,638,700 | 215,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,306,000 | 150,000 | Shares | Sole | 2022-08-12 | |
| 2021-03-31 | $5,670,600 | 130,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $12,512,500 | 250,000 | Shares | Sole | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||